These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 2575226
1. Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine. Zaczek R, Hurt S, Culp S, De Souza EB. NIDA Res Monogr; 1989; 94():223-39. PubMed ID: 2575226 [Abstract] [Full Text] [Related]
2. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB. J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644 [Abstract] [Full Text] [Related]
3. Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies. De Souza EB, Battaglia G. NIDA Res Monogr; 1989 Sep; 94():196-222. PubMed ID: 2575225 [Abstract] [Full Text] [Related]
4. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R, Kerans A, O'Neill B, Harkin A. Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283 [Abstract] [Full Text] [Related]
5. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse. Davis WM, Hatoum HT, Waters IW. Alcohol Drug Res; 1987 Jan; 7(3):123-34. PubMed ID: 2881551 [Abstract] [Full Text] [Related]
6. Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration. Zaczek R, Culp S, De Souza EB. J Neurochem; 1990 Jan; 54(1):195-204. PubMed ID: 1967142 [Abstract] [Full Text] [Related]
11. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Gollamudi R, Ali SF, Lipe G, Newport G, Webb P, Lopez M, Leakey JE, Kolta M, Slikker W. Neurotoxicology; 1989 Jan; 10(3):455-66. PubMed ID: 2576302 [Abstract] [Full Text] [Related]
14. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. Stone DM, Johnson M, Hanson GR, Gibb JW. J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215 [Abstract] [Full Text] [Related]
17. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. Schmidt CJ, Wu L, Lovenberg W. Eur J Pharmacol; 1986 May 13; 124(1-2):175-8. PubMed ID: 2424776 [Abstract] [Full Text] [Related]
18. Structure-activity relationships of MDMA-like substances. Nichols DE, Oberlender R. NIDA Res Monogr; 1989 May 13; 94():1-29. PubMed ID: 2575223 [No Abstract] [Full Text] [Related]
19. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). McKenna DJ, Peroutka SJ. J Neurochem; 1990 Jan 13; 54(1):14-22. PubMed ID: 1967141 [No Abstract] [Full Text] [Related]